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Abstract
Uterine contraction is triggered by a rise in intracellular free Ca2 concentration ([Ca2]i), and although ryanodine-
sensitive Ca2 release channels (RyRs) play a key role in the regulation of [Ca2]i in skeletal and cardiac muscle, much less is
known about their role in smooth muscle. In this study, we investigated the expression of RyR mRNAs (ryr1-3) during
human pregnancy by examining myometrial samples (n = 18) taken, with informed consent and ethical approval, from non-
pregnant patients undergoing hysterectomy, and patients undergoing elective caesarean section (at term, prior to or following
the onset of labour). Ca2 release channel expression was determined both qualitatively and quantitatively, using reverse
transcription-polymerase chain reaction (RT-PCR) analysis, RNase protection assays, and in situ mRNA hybridisation. RT-
PCR analysis demonstrated that all three ryr genes, as well as the gene encoding the type I inositol 1,4,5-trisphosphate
receptor (InsP3RI), are expressed in human myometrium. Quantitation by RNase protection assays showed that ryr3 and
InsP3RI mRNAs are the most abundant, while ryr2 mRNA is barely detectable. In situ mRNA hybridisation confirmed that
ryr3 and InsP3RI mRNAs are both localised to myometrial smooth muscle cells. The expression of ryr2 and ryr3 mRNA is
down-regulated at the end of pregnancy compared to non-pregnant myometrium, indicating that ryanodine-sensitive Ca2
release channels are differentially expressed. The relative conservation of ryr1 expression is consistent with a role for Ca2
release from ryanodine-sensitive stores in the mechanism of uterine contractility during labour. ß 1999 Elsevier Science
B.V. All rights reserved.
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1. Introduction
In human myometrium, as in other smooth
muscle, an increase in intracellular free calcium con-
centration ([Ca2]i) results in myosin light chain
phosphorylation, leading to actin-myosin interaction
and contraction [1,2]. The increase in [Ca2]i occurs
by two mechanisms [3]: entry of Ca2 through volt-
age-dependent calcium channels (VDCC) in the plas-
ma membrane (sarcolemma), and release of Ca2
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from intracellular stores. VDCCs open in response to
membrane depolarisation as action potentials prop-
agate throughout the muscle. Because myometrial
smooth muscle contraction is highly dependent on
such action potentials [3], VDCCs may play an im-
portant role in regulating uterine contraction, espe-
cially during labour. Consistent with this, RT-PCR
studies have shown an increase in the levels of
mRNA encoding VDCC subunits in rat myometrium
during pregnancy [4]. However, electrophysiological
studies revealed either no variation, or only a small
increase, in Ca2 current density [4^7], consistent
with the idea that the release of Ca2 from intracel-
lular stores may also be important.
Ca2 release from intracellular smooth muscle
stores is thought to be mediated by two families of
proteins: inositol 1,4,5-trisphosphate activated Ca2
channels (inositol 1,4,5-trisphosphate receptors, Ins-
P3Rs), and ca¡eine- and ryanodine-sensitive Ca2
release channels (ryanodine receptors, RyRs) [8,9].
RyRs are probably the sole pathway available for
Ca2 mobilisation in skeletal and cardiac muscle (re-
viewed in [10]), but functional studies in myometrial
smooth muscle using both ca¡eine and ryanodine
have given con£icting results. Some reports suggest
the stores are sensitive to both ca¡eine and ryano-
dine [11], whereas others report ryanodine-sensitive
ca¡eine-insensitive stores [12], or stores that are only
sensitive to ca¡eine [13]. Against this background, it
has recently been shown, using RT-PCR, that all
three ryr genes are expressed in the human myome-
trium during pregnancy [12,14]. Thus, although In-
sP3Rs are probably the major route for intracellular
Ca2 mobilisation in (myometrial) smooth muscle
[3,8^10], the contribution of RyRs remains to be de-
termined. In addition, the uterus undergoes substan-
tial and apparently reversible developmental changes
during adult life and pregnancy, as an accompani-
ment to major changes in hormonal milieu. These
changes may provide insights into relationships be-
tween Ca2 release channel expression, Ca2 signal-
ling and contraction.
In this study, we used RT-PCR in combination
with in situ mRNA hybridisation and RNase protec-
tion assays to quantify and localise ryr1, ryr2, ryr3
and InsP3RI mRNAs in human myometrium. We
show that ryr2 and ryr3 mRNA expression decreases
at term and during labour in human myometrium
compared to non-pregnant tissue, although ryr1 ex-
pression is conserved. We discuss the possible rele-
vance of these ¢ndings to myometrial contractility at




Human myometrial tissue (18 samples: six non-
pregnant, eight term pre-labour and four term la-
bour, one sample per woman, see Table 1) was taken
from the upper edge of the lower uterine segment
with written informed consent and Ethical Commit-
tee approval (Cambridge LREC DEC/89/56). Sam-
ples were obtained from patients undergoing either
pre-menopausal hysterectomy or caesarean section
(prior to or following the onset of labour), as shown
in Table 1. Indications for caesarean section included
a non-cephalic presentation, previous caesarean sec-
tions, failure of labour to progress and foetal dis-
tress. For control experiments, human cerebellum
was obtained during routine post mortem examina-
tions carried out within 24 h of death, and skeletal
muscle was obtained from vastus lateralis biopsies.
Tissues were quick-frozen in liquid N2 and stored at
370‡C prior to RNA extraction. For in situ hybrid-
isation, blocks of uterine smooth muscle were rapidly
frozen at 345‡C in isopentane and stored at 370‡C.
Cryostat sections (10 Wm) were cut and thaw-
mounted on silane-coated slides.
2.2. RNA isolation
Total RNA was isolated from human myome-
trium, cerebellum and skeletal muscle by the modi-
¢ed acid-guanidinium thiocyanate phenol-chloro-
form method [15], resuspended in RNase-free H2O,
and stored at 370‡C. All the samples used had intact
18S and 28S RNAs, as revealed by ethidium bromide
staining following agarose gel electrophoresis.
2.3. Oligonucleotide primers, reverse transcription and
PCR ampli¢cation
The RT-PCR methodology, using non-degenerate
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sense and antisense primers (Oswel DNA Service,
Southampton, UK), had already been optimised as
previously described [16]. Brie£y, the primers used
were as follows: (i) for ryr1 : 5P-CACTCTAGAC-
ATGTTCTCATCCTCATC-3P and 5P-ACTGGTA-
CCATCCTCAAGAGGAAATTG-3P, corresponding
to predicted amino acid residues 4466^4471 and
4616^4622 of the human skeletal type 1 RyR pro-
tein; (ii) for ryr2 : 5P-TCTGAATTCATGACCCTC-
CTGCACTTC-3P and 5P-CACTCTAGATGCTGA-
CTCTGGAACTTC-3P, corresponding to predicted
amino acid residues 4291^4295 and 4473^4479 of
the rabbit type 2 RyR protein; (iii) for ryr3 : 5P-
CACTCTAGAGGAAGAGAGTGGCATGGCTT-
3P and 5P-CACGAATTCCACCTGGTCAATGAT-
GAGCT-3P, corresponding to predicted amino acid
residues 508^512 and 663^668 of the rabbit type 3
RyR protein.
Other primers were: (iv) for InsP3RI : 5P-GTGAT-
CAAGAAAGCCTACATG-3P and 5P-TAAACGA-
AATGCTGCTCCAGA-3P, corresponding to the hu-
man sequence and giving a PCR product of 476 base
pairs (bp) [16]. Each primer pair is speci¢c for an
individual receptor, and no cross-hybridisation was
seen between any of the PCR products, which were
fully validated, including DNA sequencing, as de-
scribed in detail in previous work [16]. In this study,
ampli¢ed products were analysed directly by electro-
phoresis on 1% (w/v) agarose gels and, after transfer
onto nitrocellulose membranes (Hybond-N, Amer-
sham), by Southern hybridisation analysis.
2.4. RNase protection assay
The quality of the RNA samples was veri¢ed by
gel electrophoresis. RNase protection assays (RPA)
were performed using the HybSpeed RPA kit (Am-
bion) according to the manufacturer’s instructions.
Partial cDNAs corresponding to human ryr1-3 and
to human InsP3RI were linearised and transcribed in
vitro in the presence of [K-32P]UTP (800 Ci/mmol,
Amersham). A human actin cRNA (pTRI-L-Actin,
Ambion) was also synthesised, and used as an inter-
nal control for assay variability. Negative controls
contained yeast RNA instead of human RNA, and
human cerebellar RNA was used as a positive con-
trol. After puri¢cation by passage over Nick columns
(Pharmacia), cRNA probes (9U105 cpm) were hy-
bridised to total myometrial RNA (25 Wg of RNA
for InsP3RI and 50 Wg for each of the ryrs) in hybrid-
isation bu¡er (Ambion) for 10 min at 68‡C. Free
(non-hybridised) cRNA was removed by digestion
with a 1/25 dilution of a mixture of RNase A (1
mg/ml) and RNase T1 (20 000 units/ml) for 30 min
at 37‡C. Samples were ethanol-precipitated and re-
suspended in loading bu¡er for separation on a 4%
or 5% (w/v) polyacrylamide gel containing 8 M urea.
The gels were dried and exposed to X-ray ¢lm (Du-
pont) at 370‡C for up to 2 weeks, using intensifying
screens. Quantitation was carried out by densitome-
try using a computer-driven image analysis system
(Seescan, UK).
2.5. In situ hybridisation
Templates ligated to pGEM-T vector (Promega)
were used for cRNA synthesis as previously de-
scribed [16]. In summary, these comprised a 395 bp
ryr1 cDNA, a 582 bp ryr2 cDNA, a 423 bp ryr3
cDNA and a 476 bp InsP3RI cDNA. cRNA (anti-
sense) probes were synthesised using SP6 or T7 RNA
polymerase as previously described [16,17]. In situ
hybridisation quantitation was carried out using a
Seescan Image Analysis System (Seescan, UK) [18].
The analysis was carried out over multiple (40^50)
¢xed window areas (1000 Wm2) for each sample.
2.6. Statistics
Data were assessed by ANOVA followed by a post
hoc test. Signi¢cance was set at P6 0.05. Values are
means þ S.E.M.
3. Results
3.1. Analysis of Ca2+ release channel expression by
RT-PCR
The presence of mRNAs encoding RyR receptor
subtypes in human myometrium was determined by
RT-PCR. Although non-quantitative, the technique
clearly demonstrated the presence of the target
mRNAs in all the tested samples. Total RNA from
human cerebellum (which expresses all of the recep-
tors [16]) and from human skeletal muscle (which
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expresses ryr1 and ryr3 [16]) were used as positive
controls for the PCR reaction (results not shown).
RT-PCR con¢rmed that InsP3RI PCR ampli¢ca-
tion products were easily detectable on ethidium
bromide-stained agarose gels, suggesting that the
InsP3RI gene is highly expressed in human
myometrium. There was minimal sample-to-sample
variability (Fig. 1A). ‘Semi-quantitative’ PCR, car-
ried out by removing samples at di¡erent stages of
the PCR reaction (every four cycles from 18 to 30
cycles), showed the level of expression of InsP3RI
mRNA to be comparable between human cerebellum
and human myometrium (results not shown). Fur-
thermore, no major di¡erences in the intensity of
the 476 bp product were observed between the di¡er-
ent myometrial samples studied (non-pregnant, term
non-labour and term labour), suggesting that Ins-
P3RI expression does not change greatly during
pregnancy or labour.
Primers speci¢c for each ryr subtype showed that
mRNAs encoding all three ryr subtypes are present
in myometrium (Fig. 1B). Whereas ampli¢cation
products from human skeletal muscle or cerebellar
RNA were easily detected on ethidium bromide-
stained agarose gels (results not shown), Southern
blotting was required to detect ryr1, ryr2 and ryr3
products in uterus (Fig. 1B). Considerable sample-to-
sample variation was seen, even for ryr3, which was
the most abundantly expressed mRNA. In some
RNA samples, PCR products were not detectable
by Southern blotting even after exposure for 1
week. Although the technique is not quantitative,
these RT-PCR results suggested that the level of ex-
pression of ryr3 was greater than that of ryr2 and
Table 1
Medical details of patients and use of tissues
Sample No. Age (years) Comments Usea
Non-pregnant
1 29 Hysterectomy 1, 2
2 36 Hysterectomy 1, 2
3 28 Hysterectomy 1, 2
4 45 Hysterectomy 3
5 46 Hysterectomy 3
6 45 Hysterectomy 3
Term non-labour
7 32 Caesarian section 1
8 18 Caesarian section 1
9 30 Caesarian section 1, 2
10 37 Caesarian section 1, 2
11 24 Caesarian section 1, 2
12 26 Caesarian section 3
13 32 Caesarian section 3
14 35 Caesarian section 3
Term labour
15 34 Caesarian section 1, 2
16 35 Caesarian section 1, 2
17 24 Caesarian section 1, 2
18 32 Caesarian section 3
a1, RT-PCR; 2, RNase protection assay; 3, in situ mRNA hy-
bridisation.
Fig. 1. RT-PCR analysis of InsP3RI and ryr isoforms in human
myometrium. (A) RT-PCR was carried out on non-pregnant
(NP; lanes 1^3), term non-labour (NL; lanes 4^7) and term la-
bour (L; lanes 8^10) human myometrial RNA. The 476 bp Ins-
P3RI product was detected in human myometrium and human
cerebellum (lane 11). No product was detected in a PCR reac-
tion lacking RNA (lane 12). RNA samples without reverse
transcriptase con¢rmed the absence of genomic DNA contami-
nation (results not shown). The nucleic acid size markers are in-
dicated (M). (B) Autoradiographs of blot hybridisation analyses
of RT-PCR products from the same human uterus samples as
in A (samples 1^10, NP, NL and L), using ryr1-speci¢c
primers, ryr2-speci¢c primers and ryr3-speci¢c primers. The
autoradiographs have been over-exposed to emphasise the weak
positive signals in some lanes.
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ryr1 mRNAs for the same myometrial sample. This
hypothesis was tested by RNase protection assays.
3.2. Quantitative analysis of Ca2+ release channel
expression by RNase protection assay
RNA probes complementary to ryr (1-3) mRNA
and InsP3RI mRNA were used in RNase protection
assays (RPAs) with human L-actin cRNA as a con-
trol for assay variability. Although the relative
amounts of Q-actin and K-actin change during preg-
nancy, L-actin mRNA remains relatively constant
[19], and the level of ryr mRNA was expressed rela-
tive to L-actin mRNA.
ryr1, ryr2, ryr3 and InsP3RI mRNAs were de-
tected in human myometrium at a much lower level
than in human cerebellum (Fig. 2). ryr3 and InsP3RI
mRNA had the highest level of expression, while
ryr2 mRNA expression was barely detectable even
after 2 weeks’ exposure of the gel (Fig. 2B). There
was considerable variation in the level of expression
of Ca2 release channel mRNAs between myometrial
samples. However, quantitative densitometry of the
autoradiographs showed that ryr2 mRNA and ryr3
mRNA expression both decreased signi¢cantly at
term pregnancy (compared to non-pregnant sam-
ples). The levels of ryr1 and InsP3RI mRNA expres-
sion remained constant (Table 2).
3.3. Localisation and quantitation of ryr3 and
InsP3RI mRNA in myometrium by in situ
hybridisation
The expression of ryr3 mRNA and InsP3RI
mRNA was analysed at the cellular level by in situ
hybridisation analysis of myometrial muscle sections
Table 2
Relative expression of InsP3RI and ryr mRNAs in non-pregnant and pregnant human myometrium
Receptor
mRNA
Non-pregnant myometrium (n = 3) Term non-labour myometrium (n = 3) Term labour myometrium (n = 3)
InsP3RI 100 92 þ 10 80 þ 20
ryr1 100 109 þ 13 82 þ 3
ryr2 100 25 þ 3** 28 þ 10**
ryr3 100 58 þ 8* 48 þ 10*
The ratio of the intensities of the autoradiographic signals from ryr or InsP3RI vs. L-actin were determined for each sample. In each
case the signal intensity was normalised to the value for non-pregnant tissue (‘100%’). The values are the mean þ S.E.M.
**P6 0.01 compared with non-pregnant myometrium and *P6 0.05 compared with non-pregnant myometrium.
Fig. 2. Autoradiographs of RNase protection analysis of ryr1
(A), ryr2 (B), ryr3 (C) and InsP3RI (D) mRNA expression in
human myometrium. 50 Wg of total RNA was used for all anal-
yses with the exception of InsP3RI (25 Wg of total RNA). 50 Wg
of yeast total RNA was used as a negative control for each
probe (results not shown) and human cerebellar RNA was used
as a positive control (C, cerebellum). Lanes: 1^3, non-pregnant
myometrium; 4^6, term non-labour myometrium; 7^9, term la-
bour myometrium. The autoradiographs were exposed for ap-
prox. 20 min at room temperature for L-actin, for 5 days at
370‡C for ryr1, ryr3 and InsP3RI and for 2 weeks for ryr2.
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(Fig. 3). Expression of ryr1 and ryr2 mRNAs was
below the level of detection by this technique. Con-
trol sections exposed to ‘sense’ RNA probes showed
low background levels of hybridisation (for both
RNAs). ryr3 and InsP3RI mRNAs showed a similar
homogeneous distribution within human uterine
muscle. There was a lower level of expression of
both ryr3 and InsP3RI mRNAs in the endometrium
(results not shown). Analysis over a ¢xed area (1000
Wm2) showed a high level of expression of ryr3 and
InsP3RI mRNAs in non-pregnant human myome-
trium (147 þ 77 and 119 þ 22 silver grains for ryr3
and InsP3RI, respectively, n = 3). Expression of
both ryr3 and InsP3RI mRNA decreased during
pregnancy. For term non-labouring myometrium,
relative to non-pregnant tissue, there was a 59 þ 4%
decrease in ryr3 mRNA, and a 40 þ 4% decrease in
InsP3RI mRNA (P6 0.01, n = 3 samples and taking
3^4 sections per sample).
4. Discussion
The large size of the mRNAs encoding ryanodine
receptor isoforms (approx. 16 kb), and their low level
of expression, make quantitation di⁄cult. However,
we have shown the presence of mRNAs encoding the
three known RyR isoforms, as well as the type I
Fig. 3. (A) High-resolution views of InsP3RI mRNA distribution in human myometrium: (a) non-pregnant, (b) term non-labour,
(c) term labour, (d) background hybridisation with a ‘sense’ InsP3RI cRNA probe. (B) High-resolution views of ryr3 mRNA distribu-
tion in human myometrium: (a) non-pregnant, (b) term non-labour, (c) term labour, (d) background hybridisation with a ‘sense’ ryr3
cRNA probe. Magni¢cation U100.
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InsP3R, in human non-pregnant and pregnant myo-
metrium. We observed a di¡erential regulation of
Ca2 release channel mRNA expression during
pregnancy, in that ryr2, ryr3 and InsP3RI mRNAs
were decreased at the end of pregnancy compared
to non-pregnant myometrium, whereas ryr1 mRNA
expression remained constant. A larger decrease in
the expression of InsP3RI mRNA was detected by
in situ hybridisation compared to RNase protection
assays. This may be due to the more heterogeneous
nature of the sample used in the RNAse protection
assay, which came from a block of tissue that in-
cluded connective tissue and muscle, whereas the sil-
ver grain analysis following in situ hybridisation was
restricted to windows within identi¢ed smooth
muscle cells.
Although the presence of InsP3RI protein in hu-
man myometrium has been documented previously
[20], evidence for the expression of RyR proteins is
controversial. While ryanodine binding [12] and sin-
gle channel recording experiments [21] have shown
that RyRs do exist in myometrium, exactly which
isoform(s) are present has not been established. Early
studies demonstrated expression of ryr3 mRNA in
mouse and rabbit non-pregnant myometrium
[22,23], and more recently ryr1, ryr2, ryr3, and also
InsP3RI, InsP3RII and InsP3RIII mRNAs, have been
detected in pregnant human myometrium using RT-
PCR [12,14,24]. In the latter studies, expression of
ryr2 mRNA was not detected in non-pregnant myo-
metrium, and ryr3 mRNA expression was reported
to increase during pregnancy. In contrast, we ¢nd
Fig. 3 (continued).
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that all the ryr mRNAs are present in non-pregnant
human uterus, with ryr3 mRNA as the major ryr
species and ryr1 and ryr2 mRNAs barely detectable.
This suggests that the role of RyR-1 and RyR-2 in
human myometrium is small in comparison to RyR-
3. We also failed to detect any increase in ryr2
mRNA expression in term myometrium, and ryr3
mRNA expression decreased rather than increased
during pregnancy, in contrast to the ¢ndings de-
scribed previously. It is unclear why these discrepan-
cies exist. However, they may be related to di¡eren-
ces in technique and/or sample variability, coupled
with the very low level of expression of ryr mRNAs.
In previous work, quantitation was carried out by
PCR on random-primed cDNA, in contrast to our
RPA experiments. Also, di¡erent regions of the very
large mRNAs were targetted.
Do our ¢ndings shed any light on con£icting re-
ports concerning the action of ca¡eine on myome-
trial smooth muscle? It has been reported that rat
myometrium is ca¡eine-insensitive [25], which may
also support our suggestion that RyR-3 is the major
RyR isoform in this tissue (RyR-3 in mink lung is
also insensitive to ca¡eine [26]). However, recent ex-
periments using a full-length cDNA encoding rabbit
uterine RyR-3 expressed in HEK-293 cells con¢rmed
that uterine RyR-3 is sensitive to both ca¡eine and
ryanodine [27]. One hypothesis is that alternatively
spliced mRNA variants may be responsible for the
di¡erences in ca¡eine sensitivity of RyR-3 in tissues
such as the uterus. However, our ryr3 probe was
derived from the 5P end of ryr3 mRNA, so we could
not distinguish between the mRNAs encoding the
‘short’ (putatively ca¡eine-insensitive) or the ‘long’
(putatively ca¡eine-sensitive) type 3 RyR [28]. It is
also possible that the relative amounts of each RyR
isoform expressed in a given cell could be important
in determining the response of the cell to ca¡eine. If
the drug acts (at least in part [10]) to increase the
sensitivity of the RyR to cytoplasmic Ca2 [29], it is
possible that the density of (certain isoforms of) the
RyR, in some cells, may simply be too low to gen-
erate a sustained CICR response, even in the pres-
ence of ca¡eine. A similar argument was put forward
by Takeshima et al. [30], and has been supported by
the data of Bennett et al. [31], who showed that
ca¡eine often failed to elevate [Ca2] in cells that
expressed very low levels of RyR mRNAs. Further
support is provided by our recent ¢nding of cell to
cell heterogeneity of RyR expression in rat myome-
trial cells [32].
The considerable variability in the expression of
ryr1, ryr2 and ryr3 mRNAs between individuals, as
detected by RT-PCR or RNase protection assays, is
also of interest. The relative levels of expression of
mRNAs encoding InsP3Rs have also been found to
di¡er between individual patients [23]. These ¢ndings
raise the possibility that these individual di¡erences
could, in part, be responsible for the di¡erences in
myometrial contraction observed during human par-
turition. The decrease in intracellular Ca2 release
channel mRNA expression seen at term parallels
the decrease in VDCC mRNA expression described
by Tezuka et al. in rat [4]. It is interesting to note
that in cardiac muscle hypertrophy, ryr2 mRNA lev-
els and also RyR-2 protein decrease, suggesting there
may be a general down-regulation of the ryr2 gene in
muscle hypertrophy [33]. As the pregnant uterus
undergoes dramatic changes in size during preg-
nancy, similar regulation could occur in myometrial
smooth muscle.
The expression of ryr1 is maintained in pregnancy
compared to non-pregnant uterus. This suggests that
intracellular Ca2 mobilisation coupled to VDCC
activation may have an important role in the later
stages of pregnancy, possibly in the initiation of la-
bour. To test this idea, more studies are required to
investigate the role of RyRs in myometrial contrac-
tility, especially their possible roles in the process of
parturition.
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